DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Marriott Wardman Park Hotel

2020年1月27日 (月) 午前 7:00 - 2020年1月29日 (水) 午後 4:15

2660 Woodley Road, NW, , Washington, DC 20008 , USA

Pharmacovigilance and Risk Management Strategies Conference

Session 5: Hot Topics – Handling Emerging Trends in Pharmacovigilance

Session Chair(s)

Barbara  Morollo, RN

Barbara Morollo, RN

Head, Pharmacovigilance

Corbus Pharmaceuticals, United States

Catherine  Baldridge, MSc

Catherine Baldridge, MSc

Head of Safety

Fusion Pharmaceuticals, United States

This session will explore three hot topics and emerging trends in pharmacovigilance which include spanning discussions regarding predictive safety using translational data and non-clinical data for predicting ADRs, the impact of cannabinoids as therapeutics and research into the endocannabinoid system.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Understand the technology and factors that contribute to the ability to predict an adverse events or adverse event in a specific population
  • Identify the unique regulatory challenges surrounding cannabis and studying therapeutic benefits in investigational research

Speaker(s)

Barbara  Morollo, RN

Cannabinoids as Therapeutics

Barbara Morollo, RN

Corbus Pharmaceuticals, United States

Head, Pharmacovigilance

Glenn  Carroll, MBA

Speaker

Glenn Carroll, MBA

Deloitte, United States

Principal

Sarah  Vaughan

Yellow Card Biobank

Sarah Vaughan

Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Head of Vigilance Operations

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。